🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Systemic Lupus Erythematosus (With and Without Nephritis)

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07629583Phase 12 sites📍 Toulouse📍 Seville Genentech, Inc. · Tests: Cevostamab, Tocilizumab A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis NCT07328581Phase 24 sites📍 Chicago📍 Hawthorne📍 New Hyde Park iCell Gene Therapeutics · Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR T following lymphodepletion SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus NCT07523542Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: Autologous anti-CD19 CAR-T cells, intravenous single infusion at protocol-defined dose level (1 x 10^6 or 3 x 10^6 CAR-… A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis NCT07598396Phase 224 sites📍 CABA📍 Buenos Aires📍 Salvador Hoffmann-La Roche · Tests: Mosunetuzumab A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease NCT07085104Phase 117 sites📍 Phoenix📍 Loma Linda📍 Aurora Allogene Therapeutics · Tests: ALLO-329, Cyclophosphamide, Fludarabine Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) NCT06711887Phase 351 sites📍 Orchard Park📍 Vitória📍 Salvador Novartis Pharmaceuticals · Tests: Ianalumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy